Please login to the form below

Not currently logged in
Email:
Password:

Dominic Moorhead joins Ferring Pharmaceuticals

He takes up executive VP and chief financial officer role

Dominic MoorheadSwitzerland-based Ferring Pharmaceuticals has appointed Dominic Moorhead as its new executive vice president and chief financial officer.

Following a three-month transition period, Moorhead will assume full responsibility for the Finance, Corporate Information Systems and International Audit functions.

With over 30 years experience in the life sciences industry, Moorhead has held a number of senior roles such as strategic advisor to executives and investors in biotech, global financial controller for Takeda Pharmaceuticals, and CFO of the international business following the acquisition of Nycomed.

Prior to this, he served Hoffman- La Roche (Roche) where he was CFO of its pharma division for nine years.

Michel Pettigrew, president of the executive board and chief operating officer of Ferring, said: “His extensive experience and perspectives in finance, business and strategic development in the pharmaceutical sector make him a great fit for Ferring as we continue on our strong growth path.”

Moorhead succeeds Peter Wilden who will still continue to represent Ferring on a number of additional boards.

5th April 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics